REPL

NASDAQStock$2.69+0.27 (+10.95%)
Mkt Cap 221.7MP/E Div Yield Beta 0.74Vol 3.7M
52W$1.70
$12.63

ETFs That Hold REPL (Replimune Group, Inc.)

1M

-62.71%

3M

-64.34%

6M

-73.70%

YTD

-69.83%

1Y

-71.04%

3Y

-83.95%

5Y

-92.33%

ETFs That Hold REPL

Replimune Group, Inc. is held by 56 ETFs. The largest position by market value is in VTI (Vanguard Total Stock Market ETF).

ETFFund NameWeight
VTIVanguard Total Stock Market ETF0.00%
VXFVanguard Extended Market ETF0.01%
XBIState Street SPDR S&P Biotech ETF0.06%
IWMiShares Russell 2000 ETF0.01%
VTWOVanguard Russell 2000 ETF0.02%
IWNiShares Russell 2000 Value ETF0.01%
IBBiShares Biotechnology ETF0.02%
FESMFidelity Enhanced Small Cap ETF0.03%
IWCiShares Micro-Cap ETF0.11%
VHTVanguard Health Care ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
CNCRLoncar Cancer Immunotherapy ETF3.54%
CANCTema Oncology ETF0.53%
VFMOVanguard U.S. Momentum Factor ETF0.06%
DFASDimensional - US Small Cap ETF0.00%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VTWVVanguard Russell 2000 Value ETF0.04%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
RSSLGlobal X - Russell 2000 ETF0.02%
DFACDimensional - US Core Equity 2 ETF0.00%

Excludes leveraged and inverse ETFs.

Page 1 of 3Next

Frequently Asked Questions

How many ETFs hold REPL?
Replimune Group, Inc. (REPL) is held by 56 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VTI (Vanguard Total Stock Market ETF).
What is the largest ETF that holds REPL?
By fund size, VTI (Vanguard Total Stock Market ETF) with $2.00T in AUM holds 0.00% of its portfolio in REPL, representing $13.0M in market value.
What percentage of CNCR is REPL?
REPL makes up 3.54% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is REPL in the S&P 500?
REPL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.